Where is Sapience Therapeutics headquartered?

Sapience Therapeutics is located in Harrison, NY.

Who invested in Sapience Therapeutics?

Sapience Therapeutics has 13 investors including Geekdom Fund And Geekdom Fund.

How much funding has Sapience Therapeutics raised to date?

Sapience Therapeutics has raised ____.

When was the last funding round for Sapience Therapeutics?

Sapience Therapeutics closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

sapiencetherapeutics.com

Sapience Therapeutics

Sapience is a New York-based biotechnology firm that develops and commercializes peptide therapeutics for the treatment of cancer and infectious diseases.

Business Model:

Revenue: $2.7M

Employees: 11-50

Geographic Data

Address: 500 Mamaroneck Ave

City: Harrison

State: NY

Zip: 10528

Country: US

Financial Info

Stage:

series b

Raised Last:

$41M

Raised Total:

$72M

Social

Twitter

Crunchbase

Metrics

4,875,782Website Global Rank

1,803Website Monthly Traffic

Twitter Followers

Description

Sapience is a New York-based biotechnology firm that develops and commercializes peptide therapeutics for the treatment of cancer and infectious diseases.

Contact Phone:

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
7/2020	Venture Round		$0	Connectivity Ventures Fund Connectivity Ventures Fund
7/2016	Series A		$0	Celgene Eshelman Ventures Healthlink Capital TaiAn Technologies Celgene Eshelman Ventures Healthlink Capital TaiAn Technologies
10/2022	Grant	1	-	National Cancer Institute SBIR Development Center National Cancer Institute SBIR Development Center
5/2022	Series B		$0	Bristol Myers Squibb Eshelman Ventures Kingdon Capital NexPoint Bristol Myers Squibb Eshelman Ventures Kingdon Capital NexPoint
4/2016	Series A		$22.5M	Eshelman Ventures Celgene TaiAn Technologies Corporation
6/2020	Equity		$8M
12/2015	Debt		$300k
11/2020	Corporate Round		$14M	Bristol-Myers Squibb Company
5/2021	Grant	1	-	National Institute of Allergy and Infectious Diseases National Institute of Allergy and Infectious Diseases
12/2021	Convertible Note	1	-	NexPoint NexPoint
5/2022	Series B	4	$41M	NexPoint Bristol Myers Squibb Eshelman Ventures Bristol Myers Squibb Eshelman Ventures Kingdon Capital NexPoint
12/2021	Convertible Note	1	-	NexPoint NexPoint
5/2021	Grant	1	-	National Institute of Allergy and Infectious Diseases National Institute of Allergy and Infectious Diseases
7/2020	Venture Round	1	$8M	Connectivity Ventures Fund Connectivity Ventures Fund
7/2016	Series A	4	$22.5M	Celgene Eshelman Ventures Healthlink Capital TaiAn Technologies Celgene Eshelman Ventures Healthlink Capital TaiAn Technologies

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details